Publications by authors named "Barbara G Utterback"

Claim this Profile
S
Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
Jerry A Hall, Fujun Wang, Tina M Myers Oakes, Barbara G Utterback, Antonio Crucitti

Expert Opin Drug Saf· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.
Edward Abraham, Pierre-François Laterre, Rekha Garg, Howard Levy, Deepak Talwar, Barbara G Utterback

N Engl J Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.
Phil Barton, Andre C Kalil, Simon Nadel, Brahm Goldstein, Regina Okhuysen-Cawley, Barbara G Utterback

Pediatrics· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results.
Jean-François Dhainaut, Pierre-François Laterre, Steven P LaRosa, Howard Levy, Gary E Garber, Barbara G Utterback

Crit Care Med· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.
Jean-François Dhainaut, Pierre-François Laterre, Jonathan M Janes, Gordon R Bernard, Antonio Artigas, Barbara G Utterback

Intensive Care Med· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis